Lightchain Capital invests primarily in early-stage life sciences and software companies. The life science portfolio focuses on companies advancing treatments for multiple myeloma and related cancers.
Lightchain Capital, LLC – a venture capital fund – was started by Rodger Riney, founder of brokerage firm Scottrade. Riney, who has multiple myeloma and is focused on accelerating viable investment in scientific cancer research, established Lightchain in 2018.
People
- Drew Dennison, Managing Director
You last contacted this investor on .